Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema With C1 Esterase Inhibitor Deficiency”

116 trials

Showing 20 of 116 results

Large-scale testing (Phase 3)Study completedNCT00097695
What this trial is testing

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Who this might be right for
Angioedema
Shire 84
Large-scale testing (Phase 3)Study completedNCT06467084
What this trial is testing

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 36
Large-scale testing (Phase 3)Study completedNCT01188564
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120830
What this trial is testing

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 37
Large-scale testing (Phase 3)Study completedNCT05819775
What this trial is testing

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
CSL Behring 22
Testing effectiveness (Phase 2)Study completedNCT01359969
What this trial is testing

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 57
Large-scale testing (Phase 3)Looking for participantsNCT06679881
What this trial is testing

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 170
Large-scale testing (Phase 3)Study completedNCT04687137
What this trial is testing

Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 12
Post-approval studies (Phase 4)Active Not RecruitingNCT06806657
What this trial is testing

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

Who this might be right for
Hereditary Angioedema
CSL Behring 18
Not applicableLooking for participantsNCT07263685
What this trial is testing

Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 50
Large-scale testing (Phase 3)Study completedNCT00262288
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Not applicableStudy completedNCT01541423
What this trial is testing

A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 83
Not applicableApproved For MarketingNCT04428632
What this trial is testing

Oral Berotralstat Expanded Access Program

Who this might be right for
Hereditary AngioedemaHAEProphylaxis
BioCryst Pharmaceuticals
Not applicableNo Longer AvailableNCT04583007
What this trial is testing

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

Who this might be right for
Hereditary Angioedema (HAE)Angioedema
Shire
Not applicableStudy completedNCT05489640
What this trial is testing

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 85
Not applicableStudy completedNCT04130191
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Who this might be right for
Hereditary Angioedema (HAE)
Shire 140
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Not applicableEnrolling By InvitationNCT06262399
What this trial is testing

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 100
Not applicableLooking for participantsNCT07251933
What this trial is testing

Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 40
Post-approval studies (Phase 4)Study completedNCT06690047
What this trial is testing

Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

Who this might be right for
Hereditary Angioedema
Bernstein Clinical Research Center 5
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation